BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6276308)

  • 1. Is eosinophil chemotactic factor identical with leukotriene B?
    Czarnetzki BM
    Int Arch Allergy Appl Immunol; 1982; 67(2):181-3. PubMed ID: 6276308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the eosinophil chemotactic factor (ECF) with endogeneous hydroxyeicosatetraenoic acids of leukocytes.
    König W; Kroegel C; Kunau HW; Borgeat P
    Int Arch Allergy Appl Immunol; 1981; 66 Suppl 1():168-71. PubMed ID: 6273325
    [No Abstract]   [Full Text] [Related]  

  • 3. From eosinophil chemotactic factor of anaphylaxis to leukotriene B4--chemistry, biology and functional significance of eosinophil chemotactic leukotrienes in dermatology.
    Czarnetzki BM; Rosenbach T
    Dermatologica; 1989; 179 Suppl 1():54-9. PubMed ID: 2550288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and comparison of the eosinophil chemotactic factor with endogenous hydroxyeicosatetraenoic acids: its inhibition by arachidonic acid analogs.
    König W; Kunau HW; Borgeat P
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():301-14. PubMed ID: 6211958
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative studies on eosinophil chemotactic factors during leukocyte migration under agarose.
    Fischer N; Czarnetzki BM
    J Invest Dermatol; 1982 Oct; 79(4):222-6. PubMed ID: 7130738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the secretory activity of leukotriene B4 toward rabbit neutrophils.
    Showell HJ; Naccache PH; Borgeat P; Picard S; Vallerand P; Becker EL; Sha'afi RI
    J Immunol; 1982 Feb; 128(2):811-6. PubMed ID: 6274960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of guinea pig eosinophil chemotactic factor of anaphylaxis as leukotriene B4 and 8(S),15(S)-dihydroxy-5,9,11,13(Z,E,Z,E)-eicosatetraenoic acid.
    Sehmi R; Cromwell O; Taylor GW; Kay AB
    J Immunol; 1991 Oct; 147(7):2276-83. PubMed ID: 1655889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
    J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotrienes and lipoxygenase factors: mediators and modulators of the allergic reaction.
    Konig W; Bohn A; Bremm KD; Müller P; Szperalski B; Pfeiffer P
    Allergol Immunopathol (Madr); 1982; 10(5):385-94. PubMed ID: 6187199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediators of anaphylaxis and inflammation.
    Bach MK
    Annu Rev Microbiol; 1982; 36():371-413. PubMed ID: 6128957
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of a novel and highly potent eosinophil chemotactic lipid in human eosinophils treated with arachidonic acid.
    Morita E; Schröder JM; Christophers E
    J Immunol; 1990 Mar; 144(5):1893-900. PubMed ID: 2155268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B.
    Goetzl EJ; Pickett WC
    J Exp Med; 1981 Feb; 153(2):482-7. PubMed ID: 6264017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrapeptides of the eosinophil chemotactic factor of anaphylaxis (ECF-A) enhance eosinophil Fc receptor.
    Capron M; Capron A; Goetzl EJ; Austen KF
    Nature; 1981 Jan; 289(5793):71-3. PubMed ID: 7453810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ostertagia ostertagi: excretory secretory chemotactic substance from infective larvae as cause of eosinophil locomotion.
    Klesius PH; Haynes TB; Cross DA; Ciordia H
    Exp Parasitol; 1986 Feb; 61(1):120-5. PubMed ID: 3943588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the eosinophil chemotactic factor (ECF) release from human PMNs and rat mast cells by arachidonic acid analogs.
    Kroegel C; Kunau HW; König W
    Cell Immunol; 1981 May; 60(2):480-8. PubMed ID: 7237570
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of neutrophil-derived eosinophil chemotactic factor (ECF) in human and guinea pig skin.
    Czarnetzki BM; Frosch PJ; Vakilzadeh F; Panneck WB
    J Invest Dermatol; 1980 Feb; 74(2):109-11. PubMed ID: 7351498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophil response in guinea pig skin to a low molecular weight eosinophil chemotactic factor extracted from livers of mice with schistosomiasis.
    Tsuda S; Fukuyama K; Epstein WL
    J Invest Dermatol; 1980 Apr; 74(4):216-8. PubMed ID: 7373075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid.
    Goetzl EJ; Goldman DW; Naccache PH; Sha'afi RI; Pickett WC
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():273-82. PubMed ID: 6283846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chemotactic agents on rat and guinea pig eosinophil cytotoxicity in vitro.
    Musgrove NR; Cook RM
    Int Arch Allergy Appl Immunol; 1988; 86(3):319-24. PubMed ID: 2841243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
    Tamura N; Agrawal DK; Townley RG
    J Immunol; 1988 Dec; 141(12):4291-7. PubMed ID: 2848892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.